India should create a strong network for clinical trials, which can be used for fast recruitment of patients for trials in a short time,” Dr Kang said. Dr Shaligram of Serum Institute said the vaccine supplied by them was very cost-effective and saved millions of lives, adding it was receiving approvals for its vaccine from more countries.
“We are now engaged in adopting new technologies in a short time,” he said.
Dr Ella of Bharat Biotech said nature has been giving signals about possible threats in future and all should be prepared to work on five or six predictable diseases so that vaccines to treat them can be produced in a very short time.
“India took lead in creating huge capacities for producing COVID-19 vaccine but has to think about how these capacities will be utilized once the pandemic’s pressure reduces,” he said.